MedPath

Distinct Sources of Supplementary Protein in the Resistance Exercise Training-induced Adaptations

Not Applicable
Completed
Conditions
Dietary Supplements
Muscle Strength
Muscle, Skeletal
Diet Habit
Resistance Training
Interventions
Dietary Supplement: Animal protein
Dietary Supplement: Plant Protein
Registration Number
NCT05710614
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

This is a randomized controlled trial aimed to investigate the effects of different supplementary protein sources on muscle adaptations to resistance exercise. Young, healthy, recreationally active participants consuming an omnivorous diet with protein intake within recommended dietary allowance (RDA) (i.e.; 0.8-1.0 g.kg-1. d-1) will be recruited to undergo a 12-wk supervised resistance training program in combination with the intake of three 15-g daily doses (45g. d-1 total) of either a mixed plant- (i.e.; soy and pea protein) or animal-based (i.e.; whey protein) protein in drink form as a supplementary source of protein to their main meals of the day (i.e.; breakfast, lunch, and dinner). Before (PRE) and after (POST) the 12-wk intervention, participants will be assessed for body composition by dual-energy X-ray absorptiometry (DXA), muscle cross-sectional area (ultrasound) and fiber cross-sectional area (muscle biopsy), and maximal isotonic strength (1RM). Training consists of a resistance training (RT) program individually supervised by a researcher blinded to treatment in a laboratorial setting. Assessments will also be conducted in a blinded fashion.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Physically active (according to the International Physical Activity Questionnaire (IPAQ)
  • Absence of any chronic condition that could preclude participation in a RT program or physical testing
  • Habitual protein consumption within RDA ≥ 0.8 ≤1.0 g.kg-1. d-1
Exclusion Criteria
  • Prior history of anabolic steroids use, current or previous (≤ 3 m)
  • Use of ergogenic or protein-based supplements, current or previous (< 1 y)
  • Engagement in energy-restricted diets

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
animal proteinAnimal proteinWhey protein will be used as the active comparator for animal protein arm
plant proteinPlant ProteinA combination of pea and soy protein will be used as the experimental arm
Primary Outcome Measures
NameTimeMethod
vastus lateralis muscle cross sectional areaUltrasound images will be obtained both at baseline (before the comencement of the study) and immediately after the 12-week intervention period

the investigators used ultrasound measures of the vastus lateralis cross sectional area as the primary outcome

Secondary Outcome Measures
NameTimeMethod
lean massDXA scans will be taken both at baseline (before the comencement of the study) and immediately after the 12-week intervention period

total body and lower limb lean mass assessed by DXA

fiber cross sectional areaFiber cross sectional areas will be measured both at baseline (before the comencement of the study) and immediately after the 12-week intervention period

vastus lateralis fiber cross sectional area from muscle biopsy samples

maximal isotonic strength1-RM tests will be taken both at baseline (before the comencement of the study) and immediately after the 12-week intervention period

lower-limb maximal isotonic strength will be assessed in the leg-press exercise by means of the one-repetition-maximum test (1-RM test)

Trial Locations

Locations (1)

University of Sao Paulo

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath